Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA budget

This article was originally published in The Gray Sheet

Executive Summary

FY 2000 agriculture appropriations bill reported out of the House Appropriations Committee May 19 includes $1.2 bil. in funding related to the agency's salaries and expenses and the Prescription Drug User Fee Act. An identical amount was approved May 13 by the House Appropriations/Agriculture Subcommittee ("The Gray Sheet" May 17, p. 5). The bill also includes language prohibiting agency funds from being used to prepare a budget submission to Congress that assumes reductions from the previous year's budget due to user fee proposals, unless the submission also identifies spending reductions that should occur if the user fees are not enacted. Similar language was included last year
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT011795

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel